1,050 results on '"Rekhtman, Natasha"'
Search Results
2. Novel Insights Into the International Association for the Study of Lung Cancer Grading System for Lung Adenocarcinoma
3. Differential NEUROD1, ASCL1, and POU2F3 Expression Defines Molecular Subsets of Bladder Small Cell/Neuroendocrine Carcinoma With Prognostic Implications
4. Pathologic Assessment and Staging of Multiple Non–Small Cell Lung Carcinomas: A Paradigm Shift with the Emerging Role of Molecular Methods
5. Evolutionary characterization of lung adenocarcinoma morphology in TRACERx
6. Comparison of Immunohistochemistry, Next-generation Sequencing and Fluorescence In Situ Hybridization for Detection of MTAP Loss in Pleural Mesothelioma
7. Genomic Staging of Multifocal Lung Squamous Cell Carcinomas Is Independent of the Comprehensive Morphologic Assessment
8. High-risk features associated with recurrence in stage I lung adenocarcinoma
9. Neuroendocrine neoplasms of the lung and gastrointestinal system: convergent biology and a path to better therapies
10. Adamantinoma-like Ewing Sarcoma (ALES) May Harbor FUS Rearrangements: A Potential Diagnostic Pitfall
11. Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer
12. Single Cell Analysis of Treatment-Resistant Prostate Cancer: Implications of Cell State Changes for Cell Surface Antigen Targeted Therapies
13. Immune biomarkers and response to checkpoint inhibition of BRAFV600 and BRAF non-V600 altered lung cancers
14. Evaluation of an Integrated Spectroscopy and Classification Platform for Point-of-Care Core Needle Biopsy Assessment: Performance Characteristics from Ex Vivo Renal Mass Biopsies
15. Lung neuroendocrine neoplasms: recent progress and persistent challenges
16. Author Correction: The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers
17. Genomic and transcriptomic analysis of a library of small cell lung cancer patient-derived xenografts
18. The evolution of RET inhibitor resistance in RET-driven lung and thyroid cancers
19. The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015
20. All that is small is not a small cell carcinoma: Thoracic SMARCA4 undifferentiated tumors masquerading as SCLC
21. Invasive Mucinous Adenocarcinomas With Spatially Separate Lung Lesions: Analysis of Clonal Relationship by Comparative Molecular Profiling
22. Novel Preclinical Patient-Derived Lung Cancer Models Reveal Inhibition of HER3 and MTOR Signaling as Therapeutic Strategies for NRG1 Fusion-Positive Cancers
23. The International Association for the Study of Lung Cancer Global Survey on Programmed Death-Ligand 1 Testing for NSCLC
24. Percutaneous computed tomography guided biopsy of sub-solid pulmonary nodules: differentiating solid from ground glass components at the time of biopsy
25. SRC Family Kinase Inhibition Targets YES1 and YAP1 as Primary Drivers of Lung Cancer and as Mediators of Acquired Resistance to ALK and Epidermal Growth Factor Receptor Inhibitors
26. SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic Characterization
27. Lung-only melanoma: UV mutational signature supports origin from occult cutaneous primaries and argues against the concept of primary pulmonary melanoma
28. A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee
29. Pro: "Is Spread Through Air Spaces an In Vivo Phenomenon or an Inducible Artifact?".
30. Prognostic Implications of Small Cell Lung Cancer Transcriptional Subtyping for CNS Metastases.
31. Immunostains: Antibody Index – Solid Tumors
32. Grading (and Classification) Systems Quick Reference: Solid Tumors
33. Grading (and Classification) Quick Reference: Hematopoietic System
34. Special Stains
35. Immunostains: Antibody Index – Hematopoietic System
36. Immunostains: Hematopoietic System
37. Immunostains: Introduction
38. Immunostains: Solid Tumors
39. It Looks Like What? An Illustrated Glossary of Histopathologic Descriptors
40. Quick Clinical References for Pathologists
41. Potpourri of Quick Morphologic References
42. Tumor Syndromes
43. Tumor Genetics and Cytogenetics: Hematopoietic System
44. Tumor Genetics and Cytogenetics: Solid Tumors
45. An update on touch preparations of small biopsies
46. The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee
47. Immune-Related Pneumonitis After Chemoradiotherapy and Subsequent Immune Checkpoint Blockade in Unresectable Stage III Non–Small-Cell Lung Cancer
48. PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee
49. Three-Dimensional Histologic, Immunohistochemical, and Multiplex Immunofluorescence Analyses of Dynamic Vessel Co-Option of Spread Through Air Spaces in Lung Adenocarcinoma
50. SMARCA4-Deficient Thoracic Sarcomatoid Tumors Represent Primarily Smoking-Related Undifferentiated Carcinomas Rather Than Primary Thoracic Sarcomas
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.